Retracted] Oncogenic miR-23a-5p is associated with cellular function in RCC

Following the publication of this article, a concerned reader drew to the Editor's attention that, for the invasion and migration assay data shown in Fig. 4 on p. 2314, three pairs of data panels were overlapping, such that data which were intended to show the results from differently performed experiments were obtained from a smaller number of original sources. Moreover, after having conducted an internal investigation, the Editorial Office also observed that some of the flow cytometric data shown in Fig. 6 were duplicated in Fig. 7. Considering the number of overlapping data panels that have been identified in this published paper, the Editor of Molecular Medicine Reports has concluded that the article should be retracted from the publication on account of a lack of confidence in the integrity of the data. Upon contacting the authors about this matter, they accepted the decision to retract this paper. The Editor apologizes to the readership for any inconvenience caused, and thanks the interested reader for drawing this matter to our attention. [Molecular Medicine Reports 16: 2309-2317, 2017; DOI: 10.3892/mmr.2017.6829].

Errataetall:

RetractionOf: Mol Med Rep. 2017 Aug;16(2):2309-2317. - PMID 28656260

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:29

Enthalten in:

Molecular medicine reports - 29(2024), 5 vom: 22. März

Sprache:

Englisch

Beteiligte Personen:

Quan, Jing [VerfasserIn]
Jin, Lu [VerfasserIn]
Pan, Xiang [VerfasserIn]
He, Tao [VerfasserIn]
Lai, Yulin [VerfasserIn]
Chen, Peijie [VerfasserIn]
Lin, Canbin [VerfasserIn]
Yang, Shangqi [VerfasserIn]
Zeng, Hui [VerfasserIn]
Lai, Yongqing [VerfasserIn]

Links:

Volltext

Themen:

MiR‑23a‑5p
MicroRNA
Oncogene
Renal cell carcinoma
Retraction of Publication

Anmerkungen:

Date Revised 22.03.2024

published: Print-Electronic

RetractionOf: Mol Med Rep. 2017 Aug;16(2):2309-2317. - PMID 28656260

Citation Status PubMed-not-MEDLINE

doi:

10.3892/mmr.2024.13202

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM37006352X